Back to Journals » Drug Design, Development and Therapy » Volume 11

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Total article views   HTML views PDF downloads Totals
14,010 Dovepress* 11,976+ 1,630 13,606
PubMed Central* 2,034 418 2,452
Totals 14,010 2,048 16,058
*Since 21 March 2017

View citations on PubMed Central and Google Scholar